Home
RMD
RMD News

Latest ResMed Inc. (RMD) News on November 28, 2025

Sleep Apnea Devices Market Competitor Analysis Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts

GlobeNewswire

2 days ago

Sleep Apnea Devices Market Competitor Analysis Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts

Is ResMed's 10% Year-to-Date Gain Justified After Recent Industry Headlines?

Simply Wall St.

6 days ago

Is ResMed's 10% Year-to-Date Gain Justified After Recent Industry Headlines?

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

StockStory

7 days ago

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

Are Wall Street Analysts Predicting ResMed Stock Will Climb or Sink?

Barchart

8 days ago

Are Wall Street Analysts Predicting ResMed Stock Will Climb or Sink?

1 Large-Cap Stock to Target This Week and 2 We Brush Off

StockStory

9 days ago

1 Large-Cap Stock to Target This Week and 2 We Brush Off

Resmed CEO Mick Farrell on new technologies, tariffs and AI

MedTech Dive

11 days ago

Resmed CEO Mick Farrell on new technologies, tariffs and AI

Investing in ResMed (NYSE:RMD) five years ago would have delivered you a 21% gain

Simply Wall St.

12 days ago

Investing in ResMed (NYSE:RMD) five years ago would have delivered you a 21% gain

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

GlobeNewswire

15 days ago

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Top Stock Reports for Exxon Mobil, Home Depot & NextEra Energy

Zacks

17 days ago

Top Stock Reports for Exxon Mobil, Home Depot & NextEra Energy

MT Newswires

17 days ago

ResMed Insider Sold Shares Worth $2,000,773, According to a Recent SEC Filing

1 S&P 500 Stock to Research Further and 2 We Turn Down

StockStory

17 days ago

1 S&P 500 Stock to Research Further and 2 We Turn Down

22% Of This ResMed Insider's Holdings Were Sold

Simply Wall St.

18 days ago

22% Of This ResMed Insider's Holdings Were Sold

ResMed’s Q3 Earnings Call: Our Top 5 Analyst Questions

StockStory

22 days ago

ResMed’s Q3 Earnings Call: Our Top 5 Analyst Questions

Is Now The Time To Put ResMed (NYSE:RMD) On Your Watchlist?

Simply Wall St.

23 days ago

Is Now The Time To Put ResMed (NYSE:RMD) On Your Watchlist?

MT Newswires

24 days ago

Resmed Insider Sold Shares Worth $742,620, According to a Recent SEC Filing

MT Newswires

a month ago

RBC Lifts Price Target on ResMed to $303 From $300, Keeps Outperform Rating

MT Newswires

a month ago

Morgan Stanley Lifts Price Target on ResMed to $305 From $304, Keeps Overweight Rating

Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand

Zacks

a month ago

Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand

Is It Time To Consider Buying ResMed Inc. (NYSE:RMD)?

Simply Wall St.

a month ago

Is It Time To Consider Buying ResMed Inc. (NYSE:RMD)?

Morningstar Research

a month ago

Analyst Report: ResMed Inc.

ResMed Inc (RMD) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations

GuruFocus.com

a month ago

ResMed Inc (RMD) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations

Compared to Estimates, ResMed (RMD) Q1 Earnings: A Look at Key Metrics

Zacks

a month ago

Compared to Estimates, ResMed (RMD) Q1 Earnings: A Look at Key Metrics

ResMed (RMD) Q1 Earnings and Revenues Beat Estimates

Zacks

a month ago

ResMed (RMD) Q1 Earnings and Revenues Beat Estimates

ResMed Inc. (RMD): A Bull Case Theory

Insider Monkey

a month ago

ResMed Inc. (RMD): A Bull Case Theory

GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring

Zacks

a month ago

GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring

HIMS Stock Declines Despite Launch of New Specialty in Women's Health

Zacks

a month ago

HIMS Stock Declines Despite Launch of New Specialty in Women's Health

MT Newswires

a month ago

Morgan Stanley Adjusts Price Target on ResMed to $304 From $298, Maintains Overweight Rating

Home Healthcare Market Research Report 2025-2030: Leading Companies are Innovating and Introducing New Home Healthcare Products to Gain a Competitive Advantage

GlobeNewswire

a month ago

Home Healthcare Market Research Report 2025-2030: Leading Companies are Innovating and Introducing New Home Healthcare Products to Gain a Competitive Advantage

PolyNovo (ASX:PNV): Valuation Perspectives Following Board Appointment of ResMed Veteran Robert Douglas

Simply Wall St.

a month ago

PolyNovo (ASX:PNV): Valuation Perspectives Following Board Appointment of ResMed Veteran Robert Douglas

Zacks.com featured highlights include Stryker, NVIDIA, ResMed and Ralph Lauren

Zacks

a month ago

Zacks.com featured highlights include Stryker, NVIDIA, ResMed and Ralph Lauren

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

a month ago

Here's Why ResMed (RMD) is a Strong Growth Stock

2 Safe-and-Steady Stocks with Exciting Potential and 1 That Underwhelm

StockStory

2 months ago

2 Safe-and-Steady Stocks with Exciting Potential and 1 That Underwhelm

ResMed Insider Lowered Holding By 22% During Last Year

Simply Wall St.

2 months ago

ResMed Insider Lowered Holding By 22% During Last Year

MT Newswires

2 months ago

Resmed Insider Sold Shares Worth $823,080, According to a Recent SEC Filing

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Zacks

2 months ago

Why ResMed (RMD) is a Top Growth Stock for the Long-Term

Nyxoah Expands in the Middle East to Provide Wider Access to Genio

Zacks

2 months ago

Nyxoah Expands in the Middle East to Provide Wider Access to Genio

ResMed's (NYSE:RMD) investors will be pleased with their respectable 66% return over the last five years

Simply Wall St.

2 months ago

ResMed's (NYSE:RMD) investors will be pleased with their respectable 66% return over the last five years

Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring

Zacks

2 months ago

Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring

MT Newswires

2 months ago

Citigroup Initiates ResMed at Buy With $330 Price Target

Argus Research

2 months ago

RMD: Lowering target price to $286.00

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

GlobeNewswire

2 months ago

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 74% of the company

Simply Wall St.

2 months ago

ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 74% of the company

How Is ResMed's Stock Performance Compared to Other Healthcare Stocks?

Barchart

2 months ago

How Is ResMed's Stock Performance Compared to Other Healthcare Stocks?

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

3 months ago

Here's Why ResMed (RMD) is a Strong Growth Stock

Q2 Earnings Outperformers: ResMed (NYSE:RMD) And The Rest Of The Patient Monitoring Stocks

StockStory

3 months ago

Q2 Earnings Outperformers: ResMed (NYSE:RMD) And The Rest Of The Patient Monitoring Stocks

ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress

Insider Monkey

3 months ago

ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress

ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know

StockStory

3 months ago

ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know

Argus Research

3 months ago

RMD: Raising target price to $293.00

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

GlobeNewswire

3 months ago

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

Zacks

3 months ago

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

Argus Research

3 months ago

RMD: Lowering target price to $285.00

22% Of This ResMed Insider's Holdings Were Sold

Simply Wall St.

3 months ago

22% Of This ResMed Insider's Holdings Were Sold

3 Reasons Investors Watch ResMed (RMD)

StockStory

3 months ago

3 Reasons Investors Watch ResMed (RMD)

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

3 months ago

Here's Why ResMed (RMD) is a Strong Growth Stock

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

GlobeNewswire

3 months ago

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

Argus Research

3 months ago

RMD: Lowering target price to $299.00

Is Wall Street Bullish or Bearish on ResMed Stock?

Barchart

3 months ago

Is Wall Street Bullish or Bearish on ResMed Stock?

Respiratory Care Devices Market Landscape Report 2025-2030 Featuring Major Players - Koninklijke Philips, Medtronic, ResMed, Fisher & Paykel Healthcare, and Dragerwerk

GlobeNewswire

3 months ago

Respiratory Care Devices Market Landscape Report 2025-2030 Featuring Major Players - Koninklijke Philips, Medtronic, ResMed, Fisher & Paykel Healthcare, and Dragerwerk

ResMed Inc.'s (NYSE:RMD) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Simply Wall St.

3 months ago

ResMed Inc.'s (NYSE:RMD) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating

Investor's Business Daily

3 months ago

Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating

Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs

GlobeNewswire

3 months ago

Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs

1 Healthcare Stock Worth Investigating and 2 Facing Challenges

StockStory

3 months ago

1 Healthcare Stock Worth Investigating and 2 Facing Challenges

Argus Research

3 months ago

RMD: Raising target price to $300.00

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

GlobeNewswire

3 months ago

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

MT Newswires

3 months ago

CICC Adjusts Price Target on ResMed to $325 From $295, Maintains Outperform Rating

Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea

Zacks

3 months ago

Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea

Zacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMed

Zacks

5 months ago

Zacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMed

All You Need to Know About ResMed (RMD) Rating Upgrade to Buy

Zacks

5 months ago

All You Need to Know About ResMed (RMD) Rating Upgrade to Buy

Scoop Up These 4 GARP Stocks to Receive Handsome Returns

Zacks

5 months ago

Scoop Up These 4 GARP Stocks to Receive Handsome Returns

Argus Research

5 months ago

RMD: Raising target price to $269.00

Morningstar Research

5 months ago

Analyst Report: ResMed Inc.

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions

StockStory

5 months ago

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions

Argus Research

6 months ago

RMD: Raising target price to $265.00

Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue?

Zacks

6 months ago

Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue?

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

StockStory

6 months ago

Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks

ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?

Zacks

6 months ago

ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

StockStory

6 months ago

Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)

2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down

StockStory

6 months ago

2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down

Newsfile

6 months ago

Max Resource Corp. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

Newsfile

6 months ago

Carbone Restaurant Group is a GOLD Sponsor at the Centurion One Capital 6th Annual LA Summit

Energy Global

6 months ago

European Energy completes sale of Polish wind portfolio to Enea Group

Newsfile

6 months ago

Sienna Resources Inc. Announces Private Placement

First Foundation Bank review (2025): Personal and business banking with competitive online rates

Yahoo Personal Finance

6 months ago

First Foundation Bank review (2025): Personal and business banking with competitive online rates

Investing.com

6 months ago

Airbnb shares dip as Truist cuts stock to Sell on weak summer trends, valuation

Report: Slower economy doesn't dim downtown Austin's dynamism

Austin American-Statesman

6 months ago

Report: Slower economy doesn't dim downtown Austin's dynamism

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance

GuruFocus.com

6 months ago

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance

ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?

Zacks

6 months ago

ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

Zacks

6 months ago

Is it Worth Retaining ResMed Stock in Your Portfolio Now?

1 Surging Stock with Exciting Potential and 2 to Avoid

StockStory

6 months ago

1 Surging Stock with Exciting Potential and 2 to Avoid

Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed

TipRanks

6 months ago

Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed

1 Unpopular Stock that Should Get More Attention and 2 to Brush Off

StockStory

6 months ago

1 Unpopular Stock that Should Get More Attention and 2 to Brush Off

Here's Why ResMed (RMD) is a Strong Growth Stock

Zacks

6 months ago

Here's Why ResMed (RMD) is a Strong Growth Stock

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

Motley Fool

6 months ago

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

GlobeNewswire

6 months ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

StockStory

6 months ago

Patient Monitoring Stocks Q1 Teardown: ResMed (NYSE:RMD) Vs The Rest

Argus Research

6 months ago

RMD: Rating increased to a BUY

Argus Research

7 months ago

RMD: Raising target price to $254.00

3 Profitable Stocks to Consider Right Now

StockStory

7 months ago

3 Profitable Stocks to Consider Right Now

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

Simply Wall St.

7 months ago

Is It Smart To Buy ResMed Inc. (NYSE:RMD) Before It Goes Ex-Dividend?

This ResMed Insider Reduced Their Stake By 72%

Simply Wall St.

7 months ago

This ResMed Insider Reduced Their Stake By 72%

Share on Social Networks: